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Role of the CGIAR AMR hub
• Convene stakeholders across disciplines with interest in antimicrobial 
resistance research and development
• Provide an enabling environment for research partnerships, intensify 
collaboration within CGIAR (incl. technological platforms)
• Better communication around agriculture-associated antimicrobial 
resistance, esp. across CGIAR
– Communication of hub with a wider audience: maintain website, 
regular blogging with links to resources, add case studies
– Virtual seminars
– Communication strategy targeting different stakeholders
– Translating evidence into public messages
• Set aside seed money to initiate projects/partnerships
• Outline strategy to engage with donors shape agenda
• Stakeholder mapping and capacity development needs
Antimicrobial use, behaviour and value chains
We research behaviour around antimicrobials used, the distribution networks of 
veterinary drugs, and the role of formal and informal markets in perpetuating 
cycles of inequity.
Outputs: 
• Metrics for AM use in different systems
• Better understanding of systems 
influencing AM use behaviour
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Proportion of farmers using different 
antibiotics in Ethiopia
• Use of antibiotics (and other drugs) 
across public health and livestock 
sectors
• KAP on withdrawal period
• Anthropological research, role of 
women
• Work on metrics on antibiotics
 two workshops with vets and public 
health researchers
Use of antimicrobials 
across species

Understanding systems
Example aquaculture in Vietnam
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Understanding systems
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• System analysis suitable to facilitate 
interdisciplinary process
• Resulted in system maps with all value 
chain actors: overlay of input suppliers, 
producers, consumers, policy, 
environment
• Allowed identification of hotspots for 
AMR emergence/selection and hotspots 
for human exposure
Transmission dynamics, AMR residues
To better understand AMR risks for people, we study the biology, 
ecology, and epidemiology of resistant microbes at the animal, 
human  and environment interface. 
Outputs
• adequate study designs for genotyping research
• evidence on the extent of antimicrobial-resistant bacteria and 
antimicrobial residues found in livestock, fish, humans, the 
environment, water and food 
• transmission and genetic mechanisms of resistance in 
agriculture and health implications
AMR gene transmission in ecosystems
Samples collected in urban, peri-urban and rural eco-niches
 Several thousands of isolates being analyzed
 Phenotyping and genotyping: fill important data gaps on 
circulating strains, inform genotype surveillance
 Role of food-system linking animals and humans evident
• Bedside genotyping  with 
Nanopore technology (so far 10 
E. coli strains fully sequenced)
• Close to real time, comparably 
cheap, suitable for remote 
areas
Interventions and incentives
Based on One Health approaches, we design, test and evaluate 
interventions and incentives that lead to behavioural change and 
reduce agriculture-associated AMR. 
Outputs
• Typologies of interventions
• Decision support tools to 
identify best-bet interventions
• Gender sensitive interventions 
to mange drivers of AM use
• Cost and benefits of 
interventions from a One 
Health perspective
Community conversation as gender 
transformative approach
• Successfully piloted for other topics
• division of labour, exposure to zoonoses
• New module on AMR
• Women as caregivers to children and animals need to 
play an important role in discussions on AM use
Enabling policy environment
We translate evidence into convincing 
arguments to engage policymakers and 
other stakeholders in the AMR 
discussion. Accepted and feasible 
policies are key for sustainable solutions 
that achieve impact. 
Outputs
• Synthesized evidence for policy 
makers
• Advocacy materials
• Integrated policy approaches 
towards One Health solutions
Capacity development
Capacity development is a key enabler on the pathway to impact. 
An important area of research is how solutions can be brought to 
scale. We capitalize on a network of AMR experts to support 
capacity building on researching AMR issues and to facilitate access 
to international AMR research for professionals and institutions in 
LMICs.
Outputs
• Guidance for scaling of 
interventions 
• Training, mentorship and 
exchange programs
• Training materials
Partnerships as critical 
factor for success
Ability to excite and convene national 
partners in technical, institutional and 
policy innovations 
Ability to facilitate true One Health 
partnerships
-Ability to engage with international 
organization for effective linkages
- Adequate human and financial 
resources to establish a critical mass of 
researchers and partners
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